PROSPECTIVE EVALUATION OF CARCINOEMBRYONIC ANTIGEN LEVELS AND ALTERNATING CHEMOTHERAPEUTIC REGIMENS IN METASTATIC BREAST-CANCER

被引：57
作者：
LOPRINZI, CL
TORMEY, DC
RASMUSSEN, P
FALKSON, G
DAVIS, TE
FALKSON, HC
CHANG, AYC
机构：
[1] UNIV WISCONSIN, DEPT HUMAN ONCOL, MADISON, WI 53706 USA
[2] UNIV PRETORIA, PRETORIA, SOUTH AFRICA
[3] UNIV ROCHESTER, ST MARYS HOSP, CTR CANC, ROCHESTER, NY 14627 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 01期
关键词：
D O I：
10.1200/JCO.1986.4.1.46
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 56
页数：11
相关论文
共 33 条
[1]  
BOGDEN AE, 1978, BREAST CANCER ADV RE, V2, P283
[2]   RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER [J].
CAVALLI, F ;
GOLDHIRSCH, A ;
JUNGI, F ;
MARTZ, G ;
MERMILLOD, B ;
ALBERTO, P .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :414-419
[3]  
CHATAL JF, 1978, CLIN APPLICATION CAR, P263
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
FALKSON HC, 1979, CANCER TREAT REP, V63, P1303
[6]  
FALKSON HC, 1982, CANCER, V49, P1859, DOI 10.1002/1097-0142(19820501)49:9<1859::AID-CNCR2820490919>3.0.CO
[7]  
2-R
[8]  
FALKSON HC, 1978, CANCER, V42, P1308, DOI 10.1002/1097-0142(197809)42:3<1308::AID-CNCR2820420341>3.0.CO
[9]  
2-N
[10]   DRUG-RESISTANCE AND CANCER-CHEMOTHERAPY STRATEGY IN BREAST-CANCER [J].
GOLDIE, JH .
BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (02) :129-136
1234